The Weinbach Group, a nationally recognized healthcare marketing agency, announced it has forged a new client relationship with the Alpha-1 Foundation, an international nonprofit organization focused on finding a cure for Alpha-1 Antitrypsin Deficiency (Alpha-1) and supporting patients and families touched by the rare disease.

The Weinbach Group announced today that it is among a select group of companies that will participate in the U.S. Department of Veterans Affairs (VA) Integrated Healthcare Transformation (IHT) 2.0 contract. The 10-year, $14 billion initiative is designed to improve healthcare delivery for veterans across the nation.

The Weinbach Group Takes Home Multiple Honors At The 42nd Annual Healthcare Advertising Awards The Weinbach Group won several gold awards at this year’s Healthcare Ad Awards contest, including for this digital ad on behalf of Care First Foundation. From a provocative ad to promote the value of testing for sexually transmitted diseases to a data-rich report about the communication preferences of physicians, The Weinbach Group, once again demonstrated its expertise as a healthc

The Weinbach Group Will Spearhead PR And Marketing For The Rapidly Growing Healthcare Benefits Company The Weinbach Group, a leading...

Daniel Weinbach Will Lead Discussion On Strategies For Gaining Market Share The Weinbach Group, a leading healthcare marketing firm , announced its president and CEO, Daniel Weinbach, will moderate a panel discussion hosted by the American College of Healthcare Executives (ACHE). The event, titled "Strategic Marketing: Winning the Battle for Market and Share," will be held from 6 to 7:30 p.m. on Tuesday, December 3, 2024. Attendees will include senior executives, department

ZEO ScientifiX Hires The Weinbach Group To Increase Visibility For Its Research & Development Activities The Weinbach Group , a leading marketing communications and public relations agency, nationally recognized as a top healthcare marketing firm , announced it will begin working with ZEO ScientifiX Inc. (OTCQB: ZEOX), a Ft. Lauderdale-based clinical-stage biopharmaceutical company with a focus in the regenerative medicine space. The Miami public relations firm will work wi